Study of Autologous Total Immunoglobulin G Therapy for Atopic Dermatitis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

April 2, 2015

Primary Completion Date

March 27, 2017

Study Completion Date

March 27, 2017

Conditions
Dermatitis, Atopic
Interventions
BIOLOGICAL

Autologous immunoglobulin

Autologous immunoglobulin (total IgG) aseptically purified from the autologous plasma will be administered to the patients by intramuscular injection, once a week for 7 weeks (total 8 injections).

OTHER

Placebo

"Saline will be administered to the patients by intramuscular injection, once a week for 7weeks (total 8 injections).~(In addition, autologous immunoglobulin is colorless and odorless, injection volume is same between autologous immunoglobulin and saline)"

Trial Locations (1)

16499

Ajou university hosiptal, Suwon

All Listed Sponsors
lead

Ajou University School of Medicine

OTHER

NCT02835170 - Study of Autologous Total Immunoglobulin G Therapy for Atopic Dermatitis | Biotech Hunter | Biotech Hunter